Back to Search Start Over

Fine-mapping reveals novel alternative splicing of the dopamine transporter

Authors :
Jeffrey K. Yao
Michael E. Talkowski
Lora McClain
Douglas M. Ruderfer
Lyudmila Georgieva
Sherry Leonard
Hader Mansour
Pramod Thomas
Konasale M. Prasad
Michael John Owen
Draga Toncheva
Vishwajit L. Nimgaonkar
Michael Conlon O'Donovan
Kathleen L. McCann
Michael Chen
Kodavali V. Chowdari
Mikhil Bamne
Annie M. Watson
John P. Quinn
Patrick Sullivan
Panagiotis Papasaikas
Fabio Miyajima
George Kirov
Joel Wood
David A. Lewis
A. Javier Lopez
Source :
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. :1434-1447
Publication Year :
2010
Publisher :
Wiley, 2010.

Abstract

Center for Human Genetic Research, Massachusetts General Hospital and Department of Neurology, Harvard Medical School, Harvard University, Boston, Massachusetts.Graduate Program in Biology and Biomedical Science, Yale University, New Haven, Connecticut.The dopamine transporter gene (, ) has been implicated in the pathogenesis of numerous psychiatric and neurodevelopmental disorders, including schizophrenia (SZ). We previously detected association between SZ and intronic variants that replicated in two independent Caucasian samples, but had no obvious function. In follow-up analyses, we sequenced the coding and intronic regions of to identify complete linkage disequilibrium patterns of common variations. We genotyped 78 polymorphisms, narrowing the potentially causal region to two correlated clusters of associated SNPs localized predominantly to introns 3 and 4. Our computational analysis of these intronic regions predicted a novel cassette exon within intron 3, designated E3b, which is conserved among primates. We confirmed alternative splicing of E3b in post-mortem human substantia nigra (SN). As E3b introduces multiple in-frame stop codons, the open reading frame is truncated and the spliced product may undergo nonsense mediated decay. Thus, factors that increase E3b splicing could reduce the amount of unspliced product available for translation. Observations consistent with this prediction were made using cellular assays and in post-mortem human SN. In mini-gene constructs, the extent of splicing is also influenced by at least two common haplotypes, so the alternative splicing was evaluated in relation to SZ risk. Meta-analyses across genome-wide association studies did not support the initial associations and further post-mortem studies did not suggest case-control differences in splicing. These studies do not provide a compelling link to schizophrenia. However, the impact of the alternative splicing on other neuropsychiatric disorders should be investigated. © 2010 Wiley-Liss, Inc.

Details

ISSN :
15524841
Database :
OpenAIRE
Journal :
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Accession number :
edsair.doi.dedup.....95d849113b7008e535f699605d309c7b
Full Text :
https://doi.org/10.1002/ajmg.b.31125